AmMax Bio Announces First Patient Enrolled in Phase 2 Trial of AMB-05X For Tenosynovial Giant Cell Tumor (TGCT)

NEXT STORY
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
PREV STORY
Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update

Net cash used in operating and investing activities was $25.4 million in the first ...

author_avatar
NASDAQ Market News

Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in November 

REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News

Precision Therapeutics Reports First Quarter 2018 Financial Results

MINNEAPOLIS, May 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News